Phase II study of gemcitabine, capecitabine and cisplatin in patients with advanced pancreatic cancer.

被引：0
|
作者：
Chang, HM [1 ]
Kim, TW [1 ]
Ahn, JH [1 ]
Ryu, MH [1 ]
Lee, JS [1 ]
Kim, WK [1 ]
Kang, YK [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4219
引用
收藏
页码：368S / 368S
页数：1
相关论文
共 50 条
  • [1] Phase II study of gemcitabine and Flutamide in advanced pancreatic cancer.
    Mayer, A
    Shaw, J
    D'Ath, S
    Price, P
    Blesing, C
    Corrie, P
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 68 - 68
  • [2] A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer
    Choi, Jong Gwon
    Seo, Jae Hong
    Oh, Sang Cheul
    Choi, Chul Won
    Kim, Jun Suk
    [J]. CANCER RESEARCH AND TREATMENT, 2012, 44 (02): : 127 - 132
  • [3] A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer
    Basil F. El-Rayes
    Mark M. Zalupski
    Anthony F. Shields
    Ann Marie Ferris
    Ulka Vaishampayan
    Lance K. Heilbrun
    Raghu Venkatramanamoorthy
    Volkan Adsay
    Philip A. Philip
    [J]. Investigational New Drugs, 2005, 23 : 583 - 590
  • [4] A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer
    El-Rayes, BF
    Zalupski, MM
    Shields, AF
    Ferris, AM
    Vaishampayan, U
    Heilbrun, LK
    Venkatramanamoorthy, R
    Adsay, V
    Philip, PA
    [J]. INVESTIGATIONAL NEW DRUGS, 2005, 23 (06) : 583 - 590
  • [5] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Hong Suk Song
    Young Rok Do
    Heung Moon Chang
    Min Hee Ryu
    Kyung Hee Lee
    Yeul Hong Kim
    Dae Sik Hong
    Jae Yong Cho
    Kyoung Eun Lee
    Si Young Kim
    [J]. Cancer Chemotherapy and Pharmacology, 2008, 62 : 763 - 768
  • [6] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Song, Hong Suk
    Do, Young Rok
    Chang, Heung Moon
    Ryu, Min Hee
    Lee, Kyung Hee
    Kim, Yeul Hong
    Hong, Dae Sik
    Cho, Jae Yong
    Lee, Kyoung Eun
    Kim, Si Young
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 763 - 768
  • [7] Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study
    M Javle
    J Yu
    C Garrett
    A Pande
    B Kuvshinoff
    A Litwin
    J Phelan
    J Gibbs
    R Iyer
    [J]. British Journal of Cancer, 2009, 100 : 1842 - 1845
  • [8] Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study
    Javle, M.
    Yu, J.
    Garrett, C.
    Pande, A.
    Kuvshinoff, B.
    Litwin, A.
    Phelan, J., III
    Gibbs, J.
    Iyer, R.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 100 (12) : 1842 - 1845
  • [9] Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer
    Brodowicz, T
    Wolfram, RM
    Köstler, WJ
    Tomek, S
    Vaclavik, I
    Steger, GG
    Teleky, B
    Függer, R
    Jakesz, R
    Zielinski, CC
    [J]. ANTI-CANCER DRUGS, 2000, 11 (08) : 623 - 628
  • [10] Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer
    El-Rayes, BF
    Zalupski, MM
    Shields, AF
    Vaishampayan, U
    Heilbrun, LK
    Jain, V
    Adsay, V
    Day, J
    Philip, PA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) : 2920 - 2925
12345